Literature DB >> 23640278

Hypothalamitis: a diagnostic and therapeutic challenge.

Antonio Bianchi1, Marilda Mormando, Francesco Doglietto, Linda Tartaglione, Serena Piacentini, Libero Lauriola, Giulio Maira, Laura De Marinis.   

Abstract

To report an unusual case of biopsy-proven autoimmune hypophysitis with predominant hypothalamic involvement associated with empty sella, panhypopituitarism, visual disturbances and antipituitary antibodies positivity. We present the history, physical findings, hormonal assay results, imaging, surgical findings and pathology at presentation, together with a 2-year follow-up. A literature review on the hypothalamic involvement of autoimmune hypophysitis with empty sella was performed. A 48-year-old woman presented with polyuria, polydipsia, asthenia, diarrhea and vomiting. The magnetic resonance imaging (MRI) revealed a clear suprasellar (hypothalamic) mass, while the pituitary gland appeared atrophic. Hormonal testing showed panhypopituitarism and hyperprolactinemia; visual field examination was normal. Pituitary serum antibodies were positive. Two months later an MRI documented a mild increase of the lesion. The patient underwent biopsy of the lesion via a transsphenoidal approach. Histological diagnosis was lymphocytic "hypothalamitis". Despite 6 months of corticosteroid therapy, the patient developed bitemporal hemianopia and blurred vision, without radiological evidence of chiasm compression, suggesting autoimmune optic neuritis with uveitis. Immunosuppressive treatment with azathioprine was then instituted. Two months later, an MRI documented a striking reduction of the hypothalamic lesion and visual field examination showed a significant improvement. The lesion is stable at the 2-year follow-up. For the first time we demonstrated that "hypothalamitis" might be the possible evolution of an autoimmune hypophysitis, resulting in pituitary atrophy, secondary empty sella and panhypopituitarism. Although steroid treatment is advisable as a first line therapy, immunosuppressive therapy with azathioprine might be necessary to achieve disease control.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23640278     DOI: 10.1007/s11102-013-0487-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  22 in total

Review 1.  Lymphocytic hypophysitis. A review of 145 cases.

Authors:  N Beressi; J P Beressi; R Cohen; E Modigliani
Journal:  Ann Med Interne (Paris)       Date:  1999-06

2.  Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology.

Authors:  Rosario Pivonello; Annamaria De Bellis; Antongiulio Faggiano; Francesco Di Salle; Mario Petretta; Carolina Di Somma; Silvia Perrino; Paolo Altucci; Antonio Bizzarro; Antonio Bellastella; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

3.  From pituitary expansion to empty sella: disease progression in a mouse model of autoimmune hypophysitis.

Authors:  Isabella Lupi; Jiangyang Zhang; Angelika Gutenberg; Melissa Landek-Salgado; Shey-Cherng Tzou; Susumu Mori; Patrizio Caturegli
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

Review 4.  Intermediate uveitis.

Authors:  Adriana A Bonfioli; Francisco Max Damico; Andre L L Curi; Fernando Orefice
Journal:  Semin Ophthalmol       Date:  2005 Jul-Sep       Impact factor: 1.975

5.  Pituitary autoimmunity is associated with hypopituitarism in patients with primary empty sella.

Authors:  I Lupi; L Manetti; V Raffaelli; L Grasso; C Sardella; M Cosottini; A Iannelli; M Gasperi; F Bogazzi; P Caturegli; E Martino
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

Review 6.  Lymphocytic adenohypophysitis and lymphocytic infundibuloneurohypophysitis.

Authors:  K Hashimoto; T Takao; S Makino
Journal:  Endocr J       Date:  1997-02       Impact factor: 2.349

7.  Primary empty sella.

Authors:  Laura De Marinis; Stefania Bonadonna; Antonio Bianchi; Giulio Maira; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2005-06-21       Impact factor: 5.958

Review 8.  Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary.

Authors:  R Carpinteri; I Patelli; F F Casanueva; A Giustina
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-10       Impact factor: 4.690

Review 9.  Pituitary autoimmunity: 30 years later.

Authors:  Patrizio Caturegli; Isabella Lupi; Melissa Landek-Salgado; Hiroaki Kimura; Noel R Rose
Journal:  Autoimmun Rev       Date:  2008-05-08       Impact factor: 9.754

Review 10.  Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy.

Authors:  Juan-Andres Rivera
Journal:  Pituitary       Date:  2006       Impact factor: 3.599

View more
  5 in total

1.  Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.

Authors:  Chengyu Xu; Adriana Ricciuti; Patrizio Caturegli; C Dirk Keene; Atil Y Kargi
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

2.  Hypophysitis, Panhypopituitarism, and Hypothalamitis in a Scottish Terrier Dog.

Authors:  L Polledo; M Oliveira; J Adamany; P Graham; K Baiker
Journal:  J Vet Intern Med       Date:  2017-07-26       Impact factor: 3.333

Review 3.  Immune Checkpoint Inhibitors as a Threat to the Hypothalamus-Pituitary Axis: A Completed Puzzle.

Authors:  Agnese Barnabei; Andrea Corsello; Rosa Maria Paragliola; Giovanni Maria Iannantuono; Luca Falzone; Salvatore Maria Corsello; Francesco Torino
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

4.  Secondary autoimmune hypothalamitis with severe memory impairment 7 years after the onset of diabetes insipidus due to lymphocytic hypophysitis: a case report.

Authors:  Takahiro Asada; Shintaro Takenoshita; Mayuko Senda; Koichiro Yamamoto; Ryo Sasaki; Fumio Otsuka; Seishi Terada; Norihito Yamada
Journal:  BMC Neurol       Date:  2022-09-29       Impact factor: 2.903

5.  Anti-Ma-1 and Anti-Ma-2 Antibodies in Isolated Fatal Hypothalamitis.

Authors:  Mario Bustos; Hara Berger; Zeina Carolina Hannoush; Alejandro Ayala; Rochelle Freire; Atil Yilmaz Kargi
Journal:  J Endocr Soc       Date:  2018-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.